Clinical Trial

Development of IVF/ICSI Children Born From Different Endometrial Preparation Protocols

Study acronym: MONARTBABIES
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 16, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The efficacy and safety of endometrial preparation regimens remain controversial. In the most recent meta-analysis, using natural and modified natural cycle protocol to prepare the endometrium in frozen embryo transfer resulted in higher live birth rates. In addition, the natural cycle reduces the risk of gestational hypertension, postpartum haemorrhage, and extremely preterm delivery compared with regimens using exogenous hormones. Because there are many physiological and endocrinal differences in the frozen embryo transfer cycle with different endometrial preparation protocols, the development of children born from these regimens has received much attention. For example, there is a complete absence of the corpus luteum during the cycle of exogenous hormone administration. Or in the modified natural cycle, the pharmacokinetics is not entirely the same as the natural physiology when using an additional ovulatory injection with hCG. To date, there have been no longitudinal follow-up studies that evaluated and compared the long-term development of IVF/ICSI children born from frozen embryo transfer with different endometrial preparation protocols. Thus, the investigators conduct a follow-up of our RCT to investigate the IVF/ICSI children born from frozen embryo transfer with different endometrial preparation protocols to give strong evidence about the safety of the three most common endometrial preparation protocols in women undergoing frozen embryo transfer.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-08-14; most recent amendment 2025-09-10.
Status change: Not Yet Recruiting → Recruiting 2022-10-05
Status change: Recruiting → Not Yet Recruiting 2022-08-16
Trial Details
NCT Number NCT05502770
Lead Sponsor Mỹ Đức Hospital
Conditions Child Development, Endometrial Preparation
Enrollment 700 participants
Start Date 2022-08-12
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-16